AIFinancial Timesabout 1 hour ago
Insilico Nominates AI-Driven Lp(a) Inhibitor ISM0900
1 min read
Insilico Medicine nominated ISM0900, a potent, AI-driven, oral Lp(a) inhibitor, as a preclinical candidate for managing cardiovascular risks. The company announcement details the nomination for the drug candidate targeting Lp(a) levels.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
